Bhadhuri, Arjun, Ralph Insinga, Patrik Guggisberg, Cedric Panje, and Matthias Schwenkglenks. “Cost Effectiveness of Pembrolizumab Vs Chemotherapy As First-Line Treatment for Metastatic NSCLC That Expresses High Levels of PD-L1 in Switzerland”. Swiss Medical Weekly 149, no. 5152 (December 27, 2019): w20170. Accessed April 19, 2024. https://smw.ch/index.php/smw/article/view/2711.